SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Federica Pinna, Luca Deriu, Enrica Diana, Valeria Perra, Rachele Pisu Randaccio, Lucia Sanna, Massimo Tusconi, Bernardo Carpiniello, Clinical Global Impression-severity score as a reliable measure for routine evaluation of remission in schizophrenia and schizoaffective disorders, Annals of General Psychiatry, 2015, 14, 1

    CrossRef

  2. 2
    M. Annet Nugter, Fabiana Engelsbel, Michiel Bähler, René Keet, Remmers van Veldhuizen, Outcomes of FLEXIBLE Assertive Community Treatment (FACT) Implementation: A Prospective Real Life Study, Community Mental Health Journal, 2015,

    CrossRef

  3. 3
    Therapie Psychischer Erkrankungen, 2015,

    CrossRef

  4. 4
    Federica Pinna, Marta Bosia, Roberto Cavallaro, Bernardo Carpiniello, Consensus five factor PANSS for evaluation of clinical remission: effects on functioning and cognitive performances, Schizophrenia Research: Cognition, 2014, 1, 4, 187

    CrossRef

  5. 5
    Scott W. Woods, Barbara C. Walsh, Jean Addington, Kristin S. Cadenhead, Tyrone D. Cannon, Barbara A. Cornblatt, Robert Heinssen, Diana O. Perkins, Larry J. Seidman, Sarah I. Tarbox, Ming T. Tsuang, Elaine F. Walker, Thomas H. McGlashan, Current status specifiers for patients at clinical high risk for psychosis, Schizophrenia Research, 2014, 158, 1-3, 69

    CrossRef

  6. 6
    Alison Luciano, Gary R. Bond, Robert E. Drake, Does employment alter the course and outcome of schizophrenia and other severe mental illnesses? A systematic review of longitudinal research, Schizophrenia Research, 2014, 159, 2-3, 312

    CrossRef

  7. 7
    David Fraguas, Ángel del Rey-Mejías, Carmen Moreno, Josefina Castro-Fornieles, Montserrat Graell, Soraya Otero, Ana Gonzalez-Pinto, Dolores Moreno, Inmaculada Baeza, Mónica Martínez-Cengotitabengoa, Celso Arango, Mara Parellada, Duration of untreated psychosis predicts functional and clinical outcome in children and adolescents with first-episode psychosis: A 2-year longitudinal study, Schizophrenia Research, 2014, 152, 1, 130

    CrossRef

  8. 8
    Tea Terzić, Matej Kastelic, Vita Dolžan, Blanka Kores Plesničar, Genetic Variability Testing of Neurodevelopmental Genes in Schizophrenic Patients, Journal of Molecular Neuroscience, 2014,

    CrossRef

  9. 9
    A. Millier, U. Schmidt, M.C. Angermeyer, D. Chauhan, V. Murthy, M. Toumi, N. Cadi-Soussi, Humanistic burden in schizophrenia: A literature review, Journal of Psychiatric Research, 2014, 54, 85

    CrossRef

  10. 10
    Carlo Marchesi, Andrea Affaticati, Alberto Monici, Chiara De Panfilis, Paolo Ossola, Matteo Tonna, Predictors of symptomatic remission in patients with first-episode schizophrenia: A 16years follow-up study, Comprehensive Psychiatry, 2014, 55, 4, 778

    CrossRef

  11. 11
    J. J. McGrath, J. Miettunen, E. Jääskeläinen, F. Dark, The onset and offset of psychosis – and what happens in between, Psychological Medicine, 2014, 44, 13, 2705

    CrossRef

  12. 12
    Therapie Psychischer Erkrankungen, 2014,

    CrossRef

  13. 13
    Delphine Capdevielle, Joanna Norton, Isabelle Jaussent, Cindy Prud’homme, Stéphane Raffard, Françoise Gelly, Jean-Philippe Boulenger, Karen Ritchie, A multi-dimensional approach to insight and its evolution in first-episode psychosis: A 1-year outcome naturalistic study, Psychiatry Research, 2013, 210, 3, 835

    CrossRef

  14. 14
    E. Jaaskelainen, P. Juola, N. Hirvonen, J. J. McGrath, S. Saha, M. Isohanni, J. Veijola, J. Miettunen, A Systematic Review and Meta-Analysis of Recovery in Schizophrenia, Schizophrenia Bulletin, 2013, 39, 6, 1296

    CrossRef

  15. 15
    Miquel Bernardo, Miquel Bioque, Mara Parellada, Jerónimo Saiz Ruiz, Manuel J. Cuesta, Adrián Llerena, Julio Sanjuán, Josefina Castro-Fornieles, Celso Arango, Bibiana Cabrera, Assessing clinical and functional outcomes in a gene–environment interaction study in first episode of psychosis (PEPs), Revista de Psiquiatría y Salud Mental (English Edition), 2013, 6, 1, 4

    CrossRef

  16. 16
    Young-Chul Chung, Hyun-Min Kim, Keon-Hak Lee, Tong Zhao, Guang-Biao Huang, Tae-Won Park, Jong-Chul Yang, Clinical characteristics of patients who have recovered from schizophrenia: the role of empathy and positive-self schema, Early Intervention in Psychiatry, 2013, 7, 2
  17. 17
    Federica Pinna, Massimo Tusconi, Marta Bosia, Roberto Cavallaro, Bernardo Carpiniello, Criteria for symptom remission revisited: a study of patients affected by schizophrenia and schizoaffective disorders, BMC Psychiatry, 2013, 13, 1, 235

    CrossRef

  18. 18
    Miquel Bernardo, Miquel Bioque, Mara Parellada, Jerónimo Saiz Ruiz, Manuel J. Cuesta, Adrián Llerena, Julio Sanjuán, Josefina Castro-Fornieles, Celso Arango, Bibiana Cabrera, Criterios de valoración clínicos y de funcionamiento en un estudio de interacción gen-ambiente en primeros episodios psicóticos (PEPs), Revista de Psiquiatría y Salud Mental, 2013, 6, 1, 4

    CrossRef

  19. 19
    Rajiv Tandon, Wolfgang Gaebel, Deanna M. Barch, Juan Bustillo, Raquel E. Gur, Stephan Heckers, Dolores Malaspina, Michael J. Owen, Susan Schultz, Ming Tsuang, Jim Van Os, William Carpenter, Definition and description of schizophrenia in the DSM-5, Schizophrenia Research, 2013, 150, 1, 3

    CrossRef

  20. 20
    Miquel Bioque, Javier Goti, Jorge Capapey, Miguel Bernardo, Eficacia de los ácidos grasos omega-3 como tratamiento suplementario en la esquizofrenia, Psiquiatría Biológica, 2013, 20, 1-2, 8

    CrossRef

  21. 21
    Einblicke in das tägliche Leben, InFo Neurologie & Psychiatrie, 2013, 15, 2, 28

    CrossRef

  22. 22
    Ignacio Díaz, Jose María Pelayo-Terán, Rocío Pérez-Iglesias, Ignacio Mata, Rafael Tabarés-Seisdedos, Paula Suárez-Pinilla, José Luis Vázquez-Barquero, Benedicto Crespo-Facorro, Predictors of clinical remission following a first episode of non-affective psychosis: Sociodemographics, premorbid and clinical variables, Psychiatry Research, 2013, 206, 2-3, 181

    CrossRef

  23. 23
    Paolo Stratta, Alessandro Rossi, Short-term remission in schizophrenia as a combination of several outcome measures, Psychiatry Research, 2013, 209, 3, 401

    CrossRef

  24. 24
    Laurent Boyer, Raphaëlle Richieri, Eric Guedj, Catherine Faget-Agius, Anderson Loundou, Pierre-Michel Llorca, Pascal Auquier, Christophe Lançon, Validation of a functional remission threshold for the Functional Remission of General Schizophrenia (FROGS) scale, Comprehensive Psychiatry, 2013, 54, 7, 1016

    CrossRef

  25. 25
    Daniel R. Hanson, Irving I. Gottesman, Biologically flavored perspectives on Garmezian resilience, Development and Psychopathology, 2012, 24, 02, 363

    CrossRef

  26. 26
    F M Leweke, D Piomelli, F Pahlisch, D Muhl, C W Gerth, C Hoyer, J Klosterkötter, M Hellmich, D Koethe, Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia, Translational Psychiatry, 2012, 2, 3, e94

    CrossRef

  27. 27
    J. Meijer, C. J. P. Simons, P. J. Quee, K. Verweij, Cognitive alterations in patients with non-affective psychotic disorder and their unaffected siblings and parents, Acta Psychiatrica Scandinavica, 2012, 125, 1
  28. 28
    Bonginkosi Chiliza, Laila Asmal, Robin Emsley, Early intervention in schizophrenia in developing countries: Focus on duration of untreated psychosis and remission as a treatment goal, International Review of Psychiatry, 2012, 24, 5, 483

    CrossRef

  29. 29
    Ching-Hua Lin, Li-Shiu Chou, Chieh-Hsin Lin, Chih-Yao Hsu, Cheng-Chung Chen, Hsien-Yuan Lane, Optimizing the Early Prediction Model for Symptomatic Remission With Short-Term Treatment for Schizophrenia, Journal of Clinical Psychopharmacology, 2012, 32, 6, 773

    CrossRef

  30. 30
    O. Puig, R. Penadés, I. Baeza, V. Sánchez-Gistau, E. De la Serna, L. Fonrodona, S. Andrés-Perpiñá, M. Bernardo, J. Castro-Fornieles, Processing speed and executive functions predict real-world everyday living skills in adolescents with early-onset schizophrenia, European Child & Adolescent Psychiatry, 2012, 21, 6, 315

    CrossRef

  31. 31
    Anna-Karin Olsson, Lars Helldin, Fredrik Hjärthag, Torsten Norlander, Psychometric properties of a performance-based measurement of functional capacity, the UCSD Performance-based Skills Assessment - Brief version, Psychiatry Research, 2012, 197, 3, 290

    CrossRef

  32. 32
    Konstantinos N. Fountoulakis, Refractoriness in Bipolar Disorder: Definitions and Evidence-Based Treatment, CNS Neuroscience & Therapeutics, 2012, 18, 3
  33. 33
    A. Karow, D. Naber, M. Lambert, S. Moritz, Remission as perceived by people with schizophrenia, family members and psychiatrists, European Psychiatry, 2012, 27, 6, 426

    CrossRef

  34. 34
    Bandar AlAqeel, Howard C. Margolese, Remission in Schizophrenia: Critical and Systematic Review, Harvard Review of Psychiatry, 2012, 20, 6, 281

    CrossRef

  35. 35
    A. Karow, S. Moritz, M. Lambert, D. Schöttle, D. Naber, Remitted but still impaired? Symptomatic versus functional remission in patients with schizophrenia, European Psychiatry, 2012, 27, 6, 401

    CrossRef

  36. 36
    P. Gorwood, J. Peuskens, Setting new standards in schizophrenia outcomes: Symptomatic remission 3years before versus after the andreasen criteria, European Psychiatry, 2012, 27, 3, 170

    CrossRef

  37. 37
    Hans E. Kortrijk, Cornelis L. Mulder, Mark van der Gaag, Durk Wiersma, Symptomatic and functional remission and its associations with quality of life in patients with psychotic disorder in Assertive Community Treatment teams, Comprehensive Psychiatry, 2012, 53, 8, 1174

    CrossRef

  38. 38
    M. Oorschot, T. Lataster, V. Thewissen, M. Lardinois, J. van Os, P. A. E. G. Delespaul, I. Myin-Germeys, Symptomatic remission in psychosis and real-life functioning, The British Journal of Psychiatry, 2012, 201, 3, 215

    CrossRef

  39. 39
    Prakash Masand, Cedric O'Gorman, Francine S. Mandel, Clinical Global Impression of Improvement (CGI-I) as a valid proxy measure for remission in schizophrenia: Analyses of ziprasidone clinical study data, Schizophrenia Research, 2011, 126, 1-3, 174

    CrossRef

  40. 40
    Antonio Ciudad, Julio Bobes, Enric Álvarez, Luis San, Diego Novick, Inmaculada Gilaberte, Clinical meaningful outcomes in schizophrenia: remission and recovery, Revista de Psiquiatría y Salud Mental (English Edition), 2011, 4, 1, 53

    CrossRef

  41. 41
    P. Lepping, R. S. Sambhi, R. Whittington, S. Lane, R. Poole, Clinical relevance of findings in trials of antipsychotics: systematic review, The British Journal of Psychiatry, 2011, 198, 5, 341

    CrossRef

  42. 42
    R. Evrard, Les expériences réputées psychotiques dans la population générale : essai de problématisation, Annales Médico-psychologiques, revue psychiatrique, 2011, 169, 5, 282

    CrossRef

  43. 43
    Maria L Figueira, Sofia Brissos, Measuring psychosocial outcomes in schizophrenia patients, Current Opinion in Psychiatry, 2011, 1

    CrossRef

  44. 44
    Celso Arango, Julio Bobes, Brian Kirkpatrick, Margarida Garcia-Garcia, Javier Rejas, Psychopathology, coronary heart disease and metabolic syndrome in schizophrenia spectrum patients with deficit versus non-deficit schizophrenia: Findings from the CLAMORS study, European Neuropsychopharmacology, 2011, 21, 12, 867

    CrossRef

  45. 45
    Christoph U. Correll, Taishiro Kishimoto, Jimmi Nielsen, John M. Kane, Quantifying Clinical Relevance in the Treatment of Schizophrenia, Clinical Therapeutics, 2011, 33, 12, B16

    CrossRef

  46. 46
    Anton B.P. Staring, Mark van der Gaag, Cornelis L. Mulder, Recovery Style Predicts Remission at One-Year Follow-Up in Outpatients With Schizophrenia Spectrum Disorders, The Journal of Nervous and Mental Disease, 2011, 199, 5, 295

    CrossRef

  47. 47
    Benedicto Crespo-Facorro, Rocío Pérez-Iglesias, Ignacio Mata, Olalla Caseiro, Obdulia Martínez-Garcia, Gema Pardo, MariLuz Ramirez-Bonilla, Jose Maria Pelayo-Terán, José L. Vázquez-Barquero, Relapse prevention and remission attainment in first-episode non-affective psychosis. A randomized, controlled 1-year follow-up comparison of haloperidol, risperidone and olanzapine, Journal of Psychiatric Research, 2011, 45, 6, 763

    CrossRef

  48. 48
    Joseph Ventura, Kenneth L. Subotnik, Lisa H. Guzik, Gerhard S. Hellemann, Michael J. Gitlin, Rachel C. Wood, Keith H. Nuechterlein, Remission and recovery during the first outpatient year of the early course of schizophrenia, Schizophrenia Research, 2011, 132, 1, 18

    CrossRef

  49. 49
    Antonio Ciudad, Julio Bobes, Enric Álvarez, Luis San, Diego Novick, Inmaculada Gilaberte, Resultados clínicos relevantes en esquizofrenia: remisión y recuperación, Revista de Psiquiatría y Salud Mental, 2011, 4, 1, 53

    CrossRef

  50. 50
    T. Kurihara, M. Kato, R. Reverger, I.G.R. Tirta, Seventeen-year clinical outcome of schizophrenia in Bali, European Psychiatry, 2011, 26, 5, 333

    CrossRef

  51. 51
    S. J. Schmidt, D. R. Mueller, V. Roder, Social Cognition as a Mediator Variable Between Neurocognition and Functional Outcome in Schizophrenia: Empirical Review and New Results by Structural Equation Modeling, Schizophrenia Bulletin, 2011, 37, suppl 2, S41

    CrossRef

  52. 52
    Henrika Jormfeldt, Supporting positive dimensions of health, challenges in mental health care, International Journal of Qualitative Studies on Health and Well-Being, 2011, 6, 2

    CrossRef

  53. 53
    A. Hofer, T. Bodner, A. Kaufmann, G. Kemmler, U. Mattarei, N. M. Pfaffenberger, M. A. Rettenbacher, E. Trebo, N. Yalcin, W. W. Fleischhacker, Symptomatic remission and neurocognitive functioning in patients with schizophrenia, Psychological Medicine, 2011, 41, 10, 2131

    CrossRef

  54. 54
    Sofia Brissos, Vasco Videira Dias, Vicent Balanzá-Martinez, Ana Isabel Carita, Maria Luísa Figueira, Symptomatic remission in schizophrenia patients: Relationship with social functioning, quality of life, and neurocognitive performance, Schizophrenia Research, 2011, 129, 2-3, 133

    CrossRef

  55. 55
    Jocelyn Catty, Sarah White, Marsha Koletsi, Thomas Becker, Angelo Fioritti, Rana Kalkan, Christoph Lauber, Pascale Lissouba, Wulf Rössler, Toma Tomov, Jooske T. van Busschbach, Durk Wiersma, Tom Burns, Therapeutic relationships in vocational rehabilitation: Predicting good relationships for people with psychosis, Psychiatry Research, 2011, 187, 1-2, 68

    CrossRef

  56. 56
    María Paz Garcia-Portilla, Pilar Alejandra Saiz, Manuel Bousoño, María Teresa Bascaran, Carlos Guzmán-Quilo, Julio Bobes, Validación de la versión española de la escala de Funcionamiento Personal y Social en pacientes ambulatorios con esquizofrenia estable o inestable, Revista de Psiquiatría y Salud Mental, 2011, 4, 1, 9

    CrossRef

  57. 57
    María Paz Garcia-Portilla, Pilar Alejandra Saiz, Manuel Bousoño, María Teresa Bascaran, Carlos Guzmán-Quilo, Julio Bobes, Validation of the Spanish Personal and Social Performance scale (PSP) in outpatients with stable and unstable schizophrenia, Revista de Psiquiatría y Salud Mental (English Edition), 2011, 4, 1, 9

    CrossRef

  58. 58
    E. Simonsen, S. Friis, S. Opjordsmoen, E. L. Mortensen, U. Haahr, I. Melle, I. Joa, J. O. Johannessen, T. K. Larsen, J. I. Røssberg, B. R. Rund, P. Vaglum, T. H. McGlashan, Early identification of non-remission in first-episode psychosis in a two-year outcome study, Acta Psychiatrica Scandinavica, 2010, 122, 5
  59. 59
    F. Farzan, M. S. Barr, A. J. Levinson, R. Chen, W. Wong, P. B. Fitzgerald, Z. J. Daskalakis, Evidence for gamma inhibition deficits in the dorsolateral prefrontal cortex of patients with schizophrenia, Brain, 2010, 133, 5, 1505

    CrossRef

  60. 60
    Amresh Shrivastava, Megan Johnston, Nilesh Shah, Yves Bureau, Redefining outcome measures in schizophrenia: integrating social and clinical parameters, Current Opinion in Psychiatry, 2010, 23, 2, 120

    CrossRef

  61. 61
    Cheng-Ta Li, Tung-Ping Su, Yuan-Hwa Chou, Ying-Chiao Lee, Mu-En Liu, Hsiao-Lun Ku, Ian-Kai Shan, Ya-Mei Bai, Symptomatic Resolution Among Chinese Patients With Schizophrenia and Associated Factors, Journal of the Formosan Medical Association, 2010, 109, 5, 378

    CrossRef

  62. 62
    Marjan Drukker, Maarten Bak, Joost à Campo, Ger Driessen, Jim Van Os, Philippe Delespaul, The cumulative needs for care monitor: a unique monitoring system in the south of the Netherlands, Social Psychiatry and Psychiatric Epidemiology, 2010, 45, 4, 475

    CrossRef

  63. 63
    Jocelyn Catty, Marsha Koletsi, Sarah White, Thomas Becker, Angelo Fioritti, Rana Kalkan, Christoph Lauber, Pascale Lissouba, Wulf Rössler, Toma Tomov, Jooske T. van Busschbach, Durk Wiersma, Tom Burns, Therapeutic relationships: their specificity in predicting outcomes for people with psychosis using clinical and vocational services, Social Psychiatry and Psychiatric Epidemiology, 2010, 45, 12, 1187

    CrossRef

  64. 64
    Chang Yoon Kim, Seockhoon Chung, Joon-Noh Lee, Jun Soo Kwon, Do Hoon Kim, Chul Eung Kim, Bumseok Jeong, Yang-Whan Jeon, Min-Soo Lee, Tae-Youn Jun, Hee-Yeon Jung, A 12-week, naturalistic switch study of the efficacy and tolerability of aripiprazole in stable outpatients with schizophrenia or schizoaffective disorder, International Clinical Psychopharmacology, 2009, 24, 4, 181

    CrossRef

  65. 65
    T. Wobrock, J. Köhler, P. Klein, P. Falkai, Achieving symptomatic remission in out-patients with schizophrenia – a naturalistic study with quetiapine, Acta Psychiatrica Scandinavica, 2009, 120, 2
  66. 66
    Maarten Bak, Philippe Delespaul, Lydia Krabbendam, Karola Huistra, Wil Walraven, Jim van Os, Capturing coping with symptoms in people with a diagnosis of schizophrenia: introducing the MACS-24, International Journal of Methods in Psychiatric Research, 2009, 18, 1
  67. 67
    L. Wunderink, S. Sytema, F. J. Nienhuis, D. Wiersma, Clinical Recovery in First-Episode Psychosis, Schizophrenia Bulletin, 2009, 35, 2, 362

    CrossRef

  68. 68
    Ilya A. Lipkovich, Walter Deberdt, John G. Csernansky, Peter Buckley, Joseph Peuskens, Sara Kollack-Walker, Matthew Rotelli, John P. Houston, Defining “good” and “poor” outcomes in patients with schizophrenia or schizoaffective disorder: A multidimensional data-driven approach, Psychiatry Research, 2009, 170, 2-3, 161

    CrossRef

  69. 69
    S. Leucht, J. M. Davis, R. R. Engel, W. Kissling, J. M. Kane, Definitions of response and remission in schizophrenia: recommendations for their use and their presentation, Acta Psychiatrica Scandinavica, 2009, 119,
  70. 70
    Han Boter, Joseph Peuskens, Jan Libiger, W. Wolfgang Fleischhacker, Michael Davidson, Silvana Galderisi, René S. Kahn, Effectiveness of antipsychotics in first-episode schizophrenia and schizophreniform disorder on response and remission: An open randomized clinical trial (EUFEST), Schizophrenia Research, 2009, 115, 2-3, 97

    CrossRef

  71. 71
    I. Gasquet, F. Chartier, S. Tcherny-Lessenot, J.-P. Lépine, Étude Schizophrenia Outpatient Health Outcomes (SOHO) France : étude observationnelle à 36 mois d’une cohorte de patients schizophrènes ambulatoires traités par antipsychotiques, Revue d'Épidémiologie et de Santé Publique, 2009, 57, 1, 25

    CrossRef

  72. 72
    Richard Warner, Recovery from schizophrenia and the recovery model, Current Opinion in Psychiatry, 2009, 22, 4, 374

    CrossRef

  73. 73
    Julio Bobes, Antonio Ciudad, Enric Álvarez, Luis San, Pepa Polavieja, Inmaculada Gilaberte, Recovery from schizophrenia: Results from a 1-year follow-up observational study of patients in symptomatic remission, Schizophrenia Research, 2009, 115, 1, 58

    CrossRef

  74. 74
    Jonas Eberhard, Sten Levander, Eva Lindström, Remission in schizophrenia: analysis in a naturalistic setting, Comprehensive Psychiatry, 2009, 50, 3, 200

    CrossRef

  75. 75
    Antonio Ciudad, Enric Álvarez, Julio Bobes, Luis San, Pepa Polavieja, Inmaculada Gilaberte, Remission in schizophrenia: Results from a 1-year follow-up observational study, Schizophrenia Research, 2009, 108, 1-3, 214

    CrossRef

  76. 76
    J. Van Os, Schizophrenia treatment: content versus delivery, Acta Psychiatrica Scandinavica, 2009, 119,
  77. 77
    W. W. Fleischhacker, Second-generation antipsychotic long-acting injections: systematic review, The British Journal of Psychiatry, 2009, 195, 52, S29

    CrossRef

  78. 78
    T. Burns, J. Catty, S. White, T. Becker, M. Koletsi, A. Fioritti, W. Rossler, T. Tomov, J. van Busschbach, D. Wiersma, C. Lauber, The Impact of Supported Employment and Working on Clinical and Social Functioning: Results of an International Study of Individual Placement and Support, Schizophrenia Bulletin, 2009, 35, 5, 949

    CrossRef

  79. 79
    Malin Alenius, Margareta Hammarlund-Udenaes, Per Hartvig, Staffan Sundquist, Leif Lindström, Treatment response in psychotic patients classified according to social and clinical needs, drug side effects, and previous treatment; a method to identify functional remission, Comprehensive Psychiatry, 2009, 50, 5, 453

    CrossRef

  80. 80
    Romain Beitinger, Jingxia Lin, Werner Kissling, Stefan Leucht, Comparative remission rates of schizophrenic patients using various remission criteria, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2008, 32, 7, 1643

    CrossRef

  81. 81
    T. A. Furukawa, A. Fujita, H. Harai, R. Yoshimura, T. Kitamura, K. Takahashi, Definitions of recovery and outcomes of major depression: results from a 10-year follow-up, Acta Psychiatrica Scandinavica, 2008, 117, 1
  82. 82
    Sukanta Saha, Jan J. Barendregt, Theo Vos, Harvey Whiteford, John McGrath, Modelling disease frequency measures in schizophrenia epidemiology, Schizophrenia Research, 2008, 104, 1-3, 246

    CrossRef

  83. 83
    FREDRIK HJARTHAG, PSYCHOMETRIC PROPERTIES OF THE BURDEN INVENTORY FOR RELATIVES OF PERSONS WITH PSYCHOTIC DISTURBANCES, Psychological Reports, 2008, 103, 6, 323

    CrossRef

  84. 84
    Fredrik Hjärthag, Lars Helldin, Torsten Norlander, PSYCHOMETRIC PROPERTIES OF THE BURDEN INVENTORY FOR RELATIVES OF PERSONS WITH PSYCHOTIC DISTURBANCES1,2, Psychological Reports, 2008, 103, 2, 323

    CrossRef

  85. 85
    M. Lambert, D. Naber, A. Schacht, T. Wagner, H.-P. Hundemer, A. Karow, C. G. Huber, D. Suarez, J. M. Haro, D. Novick, R. W. Dittmann, B. G. Schimmelmann, Rates and predictors of remission and recovery during 3 years in 392 never-treated patients with schizophrenia, Acta Psychiatrica Scandinavica, 2008, 118, 3
  86. 86
    Isabelle Gasquet, Josep Maria Haro, Stéphanie Tcherny-Lessenot, Florence Chartier, Jean-Pierre Lépine, Remission in the outpatient care of schizophrenia: 3-Year results from the Schizophrenia Outpatients Health Outcomes (SOHO) Study in France, European Psychiatry, 2008, 23, 7, 491

    CrossRef

  87. 87
    Azziza Bankole, Carl I. Cohen, Ipsit Vahia, Shilpa Diwan, Nikhil Palekar, Pia Reyes, Mamta Sapra, Paul M. Ramirez, Symptomatic Remission in a Multiracial Urban Population of Older Adults with Schizophrenia, The American Journal of Geriatric Psychiatry, 2008, 16, 12, 966

    CrossRef

  88. 88
    Georg Juckel, Pier Luigi Morosini, The new approach: psychosocial functioning as a necessary outcome criterion for therapeutic success in schizophrenia, Current Opinion in Psychiatry, 2008, 21, 6, 630

    CrossRef

  89. 89
    Maarten Bak, Jim van Os, Philippe Delespaul, Arthur de Bie, Joost á Campo, Giovanni Poddighe, Marian Drukker, An observational, “real life” trial of the introduction of assertive community treatment in a geographically defined area using clinical rather than service use outcome criteria, Social Psychiatry and Psychiatric Epidemiology, 2007, 42, 2, 125

    CrossRef

  90. 90
    J. M. Haro, S. Ochoa, M. Gervin, V. Mavreas, P. Jones, Assessment of remission in schizophrenia with the CGI and CGI-SCH scales, Acta Psychiatrica Scandinavica, 2007, 115, 2
  91. 91
    E. Simonsen, S. Friis, U. Haahr, J. O. Johannessen, T. K. Larsen, I. Melle, S. Opjordsmoen, B. R. Rund, P. Vaglum, T. McGlashan, Clinical epidemiologic first-episode psychosis: 1-year outcome and predictors, Acta Psychiatrica Scandinavica, 2007, 116, 1
  92. 92
    E. Lindström, J. Eberhard, S. Levander, Five-year follow-up during antipsychotic treatment: efficacy, safety, functional and social outcome, Acta Psychiatrica Scandinavica, 2007, 116,
  93. 93
    Povl Munk-Jørgensen, Birgitte Christiansen, Ramus Licht, Happy New Year 2007, Acta Psychiatrica Scandinavica, 2007, 115, 1
  94. 94
    Stefan Leucht, Romain Beitinger, Werner Kissling, On the concept of remission in schizophrenia, Psychopharmacology, 2007, 194, 4, 453

    CrossRef

  95. 95
    Naomi A. Fineberg, Ilenia Pampaloni, Stefano Pallanti, Jonathan Ipser, Dan J. Stein, Sustained response versus relapse: the pharmacotherapeutic goal for obsessive–compulsive disorder, International Clinical Psychopharmacology, 2007, 22, 6, 313

    CrossRef

  96. 96
    Luis San, Antonio Ciudad, Enrique Álvarez, Julio Bobes, Inmaculada Gilaberte, Symptomatic remission and social/vocational functioning in outpatients with schizophrenia: Prevalence and associations in a cross-sectional study, European Psychiatry, 2007, 22, 8, 490

    CrossRef

  97. 97
    W Wolfgang Fleischhacker, Georg Kemmler, The Clinical Relevance of Percentage Improvements on the PANSS Score, Neuropsychopharmacology, 2007, 32, 11, 2435

    CrossRef

  98. 98
    Oliver Freudenreich, Daphne J. Holt, Corinne Cather, Donald C. Goff, The Evaluation and Management of Patients with First-Episode Schizophrenia: A Selective, Clinical Review of Diagnosis, Treatment, and Prognosis, Harvard Review of Psychiatry, 2007, 15, 5, 189

    CrossRef

  99. 99
    Stefan Leucht, Eleven-year clinical outcome of schizophrenia in Bali, Acta Psychiatrica Scandinavica, 2006, 114, 1
  100. 100
    B. Lachaux, La prescription au quotidien : entre références et réalité, L'Encéphale, 2006, 32, 5, 873

    CrossRef

  101. 101
    Toshiyuki Kurihara, Motoichiro Kato, Reply, Acta Psychiatrica Scandinavica, 2006, 114, 1
  102. 102
    RAJIV TANDON, STEVEN D. TARGUM, HENRY A. NASRALLAH, RUTH ROSS, Strategies for Maximizing Clinical Effectiveness in the Treatment of Schizophrenia, Journal of Psychiatric Practice, 2006, 12, 6, 348

    CrossRef

  103. 103
    Stephan Leucht, Christoph U. Correll, John M. Kane, Approaches to Treatment-Resistant Patients,
  104. 104
    Wolfram an der Heiden, Heinz Häfner, Course and Outcome,
  105. 105
    Alan Rosen, Peter Byrne, Sherilyn Goldstone, Patrick McGorry, Early Intervention for Better Mental Health Services,
  106. 106
    Katja Komossa, Christine Rummel-Kluge, Heike Hunger, Franziska Schmid, Sandra Schwarz, Lorna Duggan, Werner Kissling, Stefan Leucht, Olanzapine versus other atypical antipsychotics for schizophrenia, The Cochrane Library,
  107. 107
    Eóin Killackey, Carol Harvey, Michaela Amering, Helen Herrman, Partnerships for Meaningful Community Living: Rehabilitation and Recovery-Informed Practices,
  108. 108
    Katja Komossa, Christine Rummel-Kluge, Sandra Schwarz, Franziska Schmid, Heike Hunger, Werner Kissling, Stefan Leucht, Risperidone versus other atypical antipsychotics for schizophrenia, The Cochrane Library,